Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday


U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

  • Rocket Pharmaceuticals, Inc. RCKT shares climbed 31.8% to $20.15 after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease.
  • ECARX Holdings Inc. ECX gained 16.8% to $3.5628.
  • VEON Ltd. VEON surged 16.4% to $19.30.
  • HireRight Holdings Corporation HRT rose 14.8% to $10.05. HireRight plans additional $25 million share repurchase program.
  • VEON Ltd. VEON gained 14.6% to $19.00.
  • Sigma Lithium Corporation SGML climbed 13.7% to $36.54.
  • NextNav Inc. NN gained 10.4% to $5.60.
  • REV Group, Inc. REVG gained 9.2% to $14.07 after the company reported better-than-expected third-quarter financial results and raised FY23 net sales guidance above estimates.

Also Read: QUALCOMM, McKesson And 2 Other Stocks Insiders Are Selling

  • The Hain Celestial Group, Inc. HAIN rose 7.2% to $10.48. Hain Celestial targets $130 million to $150 million of annualized savings and a $165 million conversion of working capital cash by FY27.
  • Amprius Technologies, Inc. AMPX gained 7% to $4.32.
  • Navios Maritime Partners L.P. NMM climbed 6.8% to $23.20.
  • Moderna, Inc. MRNA surged 5.6% to $111.37 after the company announced business and clinical updates across its franchises, introduced several new development programs and long term guidance.
  • Carpenter Technology Corporation CRS gained 5.4% to $67.72. Benchmark maintained Carpenter Tech with a Buy and raised the price target from $65 to $100.

Now Read This: Around $8M Bet On Southwest Gas Holdings? Check Out These 4 Stocks Insiders Are Buying

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading Ideasbig gainersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!